Canakinumab induces remission in a patient with resistant familial Mediterranean fever

Rheumatology (United Kingdom)

Volumn 51, Issue 6, 2012, Pages 1041-

  Hacihamdioglu, Duygu Ovunc ^a   Ozen, Seza ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CANAKINUMAB; COLCHICINE; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SERUM AMYLOID A; TUMOR NECROSIS FACTOR INHIBITOR;

ADOLESCENT; CASE REPORT; DRUG TREATMENT FAILURE; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HOMOZYGOSITY; HUMAN; NOTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; REMISSION; SACROILIITIS; SHOULDER ARTHRITIS; TREATMENT RESPONSE;

ADOLESCENT; ANTIBODIES, MONOCLONAL; C-REACTIVE PROTEIN; DRUG RESISTANCE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; INTERLEUKIN-1BETA; REMISSION INDUCTION;

EID: 84861465324     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes021     Document Type: Note

References (1)

1. Chae JJ, Aksentijevich I, Kastner DL. Advances in the understanding of familial mediterranean fever and possibilities for targeted theraphy. Br J Haematol 2009;146: 467-78.